Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Change in Account Payables (2016 - 2025)

Orthofix Medical (OFIX) has disclosed Change in Account Payables for 15 consecutive years, with $8.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Account Payables rose 42.25% year-over-year to $8.3 million, compared with a TTM value of $2.6 million through Dec 2025, up 146.65%, and an annual FY2025 reading of $2.6 million, up 146.65% over the prior year.
  • Change in Account Payables was $8.3 million for Q4 2025 at Orthofix Medical, up from $3.5 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $8.3 million in Q4 2025 and bottomed at -$6.7 million in Q2 2024.
  • Average Change in Account Payables over 5 years is $610250.0, with a median of -$570500.0 recorded in 2021.
  • The sharpest move saw Change in Account Payables tumbled 5303.57% in 2021, then surged 580.41% in 2022.
  • Year by year, Change in Account Payables stood at $7.2 million in 2021, then tumbled by 123.12% to -$1.7 million in 2022, then skyrocketed by 362.88% to $4.4 million in 2023, then skyrocketed by 31.95% to $5.8 million in 2024, then soared by 42.25% to $8.3 million in 2025.
  • Business Quant data shows Change in Account Payables for OFIX at $8.3 million in Q4 2025, $3.5 million in Q3 2025, and -$6.6 million in Q2 2025.